Yara Tedavisinde Hiperbarik Oksijen Tedavisi’nin Yeri
Özet
Hiperbarik Oksijen Tedavisi (HBOT), basınç odasında normal atmosfer basıncından yüksek basınçlarda %100 oksijen solutulması esasına dayanan ve plazmada yüksek miktarda oksijen çözünmesini sağlayarak doku hipoksisini önleyen yardımcı bir tedavi yöntemidir. Kronik ve iyileşmeyen yaraların temelinde yatan hipoksi, ödem ve enfeksiyon döngüsünü antihipoksik, antiinflamatuar ve antienfeksiyöz özellikleri ile kırarak yara iyileşme sürecini tersine çevirir. HBOT; fibroblastik aktiviteyi, kolajen sentezini, granülasyon dokusu artışını ve neovaskülarizasyonu (anjiogenez ve vaskülojenez) hücresel düzeyde uyarır. Özellikle Wagner sınıflamasına göre evre 3 ve 4 diyabetik ayak enfeksiyonlarında tam iyileşme oranlarını artırırken, majör ampütasyon ihtiyacını anlamlı derecede azaltır. Epitelizasyon sürecini epidermal keratinositlerin çoğalmasını ve göçünü hızlandırarak destekleyen bu tedavi, büyüme faktörleri ve lokal oksijen seviyelerine doğrudan bağlıdır. Enfeksiyon kontrolünde ise reaktif oksijen türleri (ROS) aracılığıyla doğrudan bakterisidal etki gösterir, nötrofil fonksiyonlarını artırarak bağışıklık sistemini güçlendirir ve belirli antibiyotik grupları ile sinerjik bir antimikrobiyal etki yaratır. Sonuç olarak HBOT; diyabetik ayak, vaskülit, radyonekroz, donma ve yanık gibi iskemik veya problemli yaraların fizyolojik mekanizmalarını hücresel ve biyokimyasal düzeyde regüle ederek iyileşme sürelerini belirgin şekilde kısaltmaktadır.
Hyperbaric Oxygen Therapy (HBOT) is an adjunctive treatment method based on intermittently breathing 100% oxygen in a pressure chamber at pressures higher than 1 ATA, which reverses delayed wound healing by dissolving high amounts of oxygen in plasma and breaking the hypoxia, edema, and infection cycle in non-healing wounds through its anti-hypoxic, anti-inflammatory, and anti-infectious properties. At the cellular level, HBOT stimulates fibroblastic activity, collagen synthesis, granulation tissue growth, and neovascularization while significantly increasing complete healing rates and reducing major amputation requirements particularly in Wagner Grade 3 and 4 diabetic foot infections. This therapy directly accelerates epithelialization by enhancing epidermal keratinocyte proliferation and migration depending on local oxygen levels and growth factors, and it contributes to infection control by exerting direct bactericidal effects via reactive oxygen species (ROS), strengthening the immune system through enhanced neutrophil functions, and displaying synergistic antimicrobial interactions with specific antibiotics. Consequently, HBOT shortens the recovery period of problematic wounds like diabetic feet, vasculitis, radionecrosis, frostbite, and burns by regulating physiological, cellular, and biochemical mechanisms.
Referanslar
Taylor CT, Pouyssegur J. Oxygen, hypoxia and stress. Ann N Y Acad Sci. 2007;1113:87- 94.
Tandara AA, Mustoe TA. Oxygen in wound healing-more than a nutrient. World J. Surg. 2004;28:294-300.
Gupta S, Laskar N, Kadouri DE. Evaluating the effect of oxygen concentrations on antibiotic sensitivity, growth, and biofilm formation of human pathogens. Microbiol Insights. 2016 Nov 16;9:37-46.
Bitterman H, Cohen L. Effects of hyperbaric oxygen in circulatory shock induced by splanchnic artery occlusion and reperfusion in rats. Can J Physiol pharmacol. 1989;67:1033-1037.
Ağir H, Mersa B, Aktaş S, Olgaç V. Histologic effects of hyperbaric oxygen therapy administered immediately after or two hours after ischemia-reperfusion injury: a rat abdominal skin flap model. Kulak Burun Bogaz Ihtis Derg. 2003 Jan;10 (1):18-24.
Stephens FO, Hunt TK. Effect of changes in inspired oxygen and carbon dioxide tensions on wound tensile strength: An experimental study. Ann Surg. 1971;173:515-519.
Krogh A. The number and distribution of capillaries in muscle with calculations of the oxygen pressure head necessary for supplying the tissue. J Physiol. 1919 ;52:409-415
Neuman TS, Thom SR. Oxygen and the Basic Mechanisms of Wound Healing. In: Hopf HW, Kelly Matthew, Shapshak D, eds. Physiology and Medicine of Hyperbaric Oxygen Therapy. 1 st ed. Philadelphia: Saunders 2008. p. 219
Doctor N, Pandya S, Supe A. Hyperbaric oxygen therapy in diabetic foot J Postgrad Med. 1992;38 (3):112-4, 111.
Abidia A, Laden G, Kuhan G, Johnson BF, Wilkinson AR, Renwick PM, et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double-blind randomised-controlled trial. Eur J Vasc Endovasc Surg. 2003;25 (6):513-8.
Kalani M, Jörneskog G, Naderi N, Lind F, Brismar K. Hyperbaric oxygen (HBO) therapy in treatment of diabetic foot ulcers. Long-term follow-up. J Diabetes Complications. 2002;16(2):153-8.
Kessler L, Bilbault P, Ortega F, Grasso C, Passemard R, Stephan D, et al. Hyperbaric oxygenation accelerates the healing rate of nonischemic chronic diabetic foot ulcers: a prospective randomized study. Diabetes Care. 2003;26(8):2378-82.
Löndahl M, Katzman P, Nilsson A, Hammarlund C. Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes. Daibetes Care. 2010;33(5):998-1003.
Faglia E, Favales F, Aldeghi A, Calia P, Quarantiello A, Oriani G, et al. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study. Diabetes Care. 1996;19(12):1338-43.
Sharma R, Sharma SK, Mudgal SK, Jelly P,Thakur K. Efficacy of hyperbaric oxygen therapy for diabetic foot ulcer, a systematic review and meta-analysis of controlled clinical trials. Scientifc Reports, 2021;11:2189
Fosen KM,Thom SR. Hyperbaric Oxygen, Vasculogenic Stem Cells, and Wound Healing. Antioxid Redox Signal. 2014 Oct 10;21(11):1634–1647.
Sheikh AY, Gibson JJ, Rollins MD, Hopf HW, Hussain Z, Hunt TK. Effect of Hyperoxia on Vascular Endothelial Growth Factor Levels in a Wound Model. Arch Surg.2000;135(11):1293-1297.
Zamboni WA,Browder LK,Martinez. Hyperbaric oxygen and wound healing. J. Clin Plast Surg. 2003 Jan;30(1):67-75
Kairuz E, Upton Z, Dawson RA, Malda J. Hyperbaric oxygen stimulates epidermal reconstruction in human skin equivalents. Wound Repair Regen. 2007;15(2):266-74.
Hunt TK, Niinikoski J, Zederfeldt B. Role of oxygen in repair processes. Acta Chir Scand. 1972;138(2):109-10.
Myllylä R, Tuderman L, Kivirikko KI. Mechanism of the prolyl hydroxylase reaction 2. Kinetic analysis of the reaction sequence. Eur J Biochem. 1977;80(2):349-57.
Udenfriend S. Formation of hydroxyproline in collagen. Science.1966 Jun 3;152(3727):1335-40
Hopf HW, Gibson JJ, Angeles AP, Constant JS, Feng JJ, Rollins MD, et al. Hyperoxia and angiogenesis. Wound Repair Regen. 2005;13(6):558-64.
Jain KK. HBO Therapy in Wound Healing, Plastic Surgery, and Dermatology. Textbook of Hyperbaric Medicine. 6th ed. Basel: Springer 2017. p. 187.
Tepper OM, Capla JM, Galiano RD and et al. Adult vasculogenesis occurs through in situ recruitment, proliferation, and tubulization of circulating bone marrow-derived cells. Blood 2005;105:1068-77.
Knighton DR, Silver IA, Hunt TK. Regulation of wound-healing angiogenesis: Effect of oxygen gradients and inspired oxygen concentration. Surgery. 1981;90:262-270.
Oley MH, Oley MC,Tjandra DE, Sedu SW, Sumarauw ERN, Aling DMR, Kalangi JA, Islam AA, Hatta M, Faruk M. Hyperbaric oxygen therapy in the healing process of foot ulcers in diabetic type 2 patients marked by interleukin 6, vascular endothelial growth factor, and PEDIS score: A randomized controlled trial study. International Journal of Surgery Open. 2020; Volume 27, p.154-161.
Ergözen S,The Effects of Hyperbaric Oxygen Treatment on Hypoxia Inducible Factor-1α, Inducible Nitric Oxide Synthase and Vascular Endothelial Growth Factor Levels in Patients with Diabetic Foot Wound . Medical Journal of Mugla Sitki Kocman University 2019;6(3):142-146
Calvert JW, Cahil J, Yamaguchi-Okada M, Zhang JH. Oxygen treatment after experimental hypoxia-ischemia in neonatal rats alters the expression of HIF-1α and its downstream target genes. J Appl Physiol. 2006;101, 853-865.
Zhang Q, Chang Q, Cox RA, Gong X, Gould LJ. Hyperbaric oxygen decreases inflammation in an ishemic wound model. Journal of Investigate Dermatology. 2008;128, 2102-2112.
Ostrowski RP, Colohan AR, Zhang JH. Mechanisms of hyperbaric oxygen-induced neuroprotection in a rat model of subarachnoid hemorrhage. J Cereb Blow Flow Metab. 2004;25, 554-571.
Jensen JA, Hunt TK, Scheuenstuhl H and et al, Effect of lactate, pyruvate, and pH on secretion and mitogenesis factors by macrophages, Lab. Invest. 1986;54, 574-578
Hussain MZ, Ghani PQ, and Hunt TK, Inhibition of prolyl hydroxylase by poly (ADP-ribose) and phosphoribosyl-AMP, J. Biol. Chem. 1989;264, 7850-7855.
Neuman TS, Thom SR. Oxygen and the Basic Mechanisms of Wound Healing. In: Hopf HW, Kelly Matthew, Shapshak D, eds. Physiology and Medicine of Hyperbaric Oxygen Therapy. 1 st ed. Philadelphia: Saunders 2008. p. 212.
Dimitrijevich SD, Paranjape S, Wilson JR, Gracy RW, Mills JG. Effect of hyperbaric oxygen on human skin cells in culture and in human dermal and skin equivalents. Wound Repair Regen 1999;7(1):53-64.
Sander AL,Henrich D,Muth CM,Marzi I,Barker JH, Frank JM. In vivo effect of hyperbaric oxygen on wound angiogenesis and epithelialization. Wound Repair Regen Mar-Apr 2009;17(2):179-84.
Semadi NI. The Role of VEGF and TNF-Alpha on Epithelialization of Diabetic Foot Ulcers after Hyperbaric Oxygen Therapy. Open Access Maced J Med Sci.2019 Oct 15;7(19):3177–3183.
Gallagher KA, Goldstein LJ,Thom SR, Velazquez OC. Hyperbaric oxygen and bone marrow-derived endothelial progenitor cells in diabetic wound healing. Vascular. Nov-Dec 2006;14(6):328-37.
Kaide CG, Khandelwal S. Hyperbaric oxygen: applications in infectious disease. Emerg. Med. Clin. North Am. 2008;26(2)571–595.
Vatansever F, Melo WC, Avci P, Vecchio D, Sadasivam M, Gupta A, Chandran R, Karimi M, Parizotto NA, Yin R. Antimicrobial strategies centered around reactive oxygen species–bactericidal antibiotics, photodynamic therapy, and beyond. FEMS Microbiol. Rev. 2013;37(6)955–989.
Dryden M. Reactive oxygen therapy: a novel therapy in soft tissue infection. Curr. Opin. Infect. Dis. 2017;30(2):143–149.
Dunnill C, Patton T, Brennan J, Barrett J, Dryden M, Cooke J, Leaper D, Georgopoulos NT. Reactive oxygen species (ROS) and wound healing: the functional role of ROS and emerging ROS-modulating technologies for augmentation of the healing process. Int. Wound J. 2017;14(1)89–96.
Winterbourn CC, Kettle AJ, Hampton MB. Reactive oxygen species and neutrophil function. Annu. Rev. Biochem. 2016;85:765–792.
Memar MY, Yekani M, Naser Alizadeh N, Baghi HB. Hyperbaric oxygen therapy: Antimicrobial mechanisms and clinical application for infections. Biomedicine & Pharmacotherapy. 2019;109:440–447.
